ESG News

As a pioneer in the biotechnology industry, Grape King Bio’s Hericium Erinaceus has undergone 12 years of research and development. Our unique technology patent “Erinacine A” has enhanced the active ingredient to the highest level in the industry and can now be cultivated using the world's largest mass production. This award demonstrates Grape King Bio’s long-term commitment to the R&D of new botanical drugs and capture the family neurological health care market to become one of the leading experts in the industry.